Literature DB >> 12917346

Morphine induces desensitization of insulin receptor signaling.

Yu Li1, Shoshana Eitan, Jiong Wu, Christopher J Evans, Brigitte Kieffer, Xiaojian Sun, Roberto D Polakiewicz.   

Abstract

Morphine analgesia is mediated principally by the micro -opioid receptor (MOR). Since morphine and other opiates have been shown to influence glucose homeostasis, we investigated the hypothesis of direct cross talk between the MOR and the insulin receptor (IR) signaling cascades. We show that prolonged morphine exposure of cell lines expressing endogenous or transfected MOR, IR, and the insulin substrate 1 (IRS-1) protein specifically desensitizes IR signaling to Akt and ERK cascades. Morphine caused serine phosphorylation of the IR and impaired the formation of the signaling complex among the IR, Shc, and Grb2. Morphine also resulted in IRS-1 phosphorylation at serine 612 and reduced tyrosine phosphorylation at the YMXM p85-binding motifs, weakening the association of the IRS-1/p85 phosphatidylinositol 3-kinase complex. However, the IRS-1/Grb2 complex was unaffected by chronic morphine treatment. These results suggest that morphine attenuates IR signaling to Akt by disrupting the IRS-1-p85 interaction but inhibits signaling to ERK by disruption of the complex among the IR, Shc, and Grb2. Finally, we show that systemic morphine induced IRS-1 phosphorylation at Ser612 in the hypothalamus and hippocampus of wild type, but not MOR knockout, mice. Our results demonstrate that opiates can inhibit insulin signaling through direct cross talk between the downstream signaling pathways of the MOR and the IR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917346      PMCID: PMC180943          DOI: 10.1128/MCB.23.17.6255-6266.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  77 in total

1.  Akt mediates sequestration of the beta(2)-adrenergic receptor in response to insulin.

Authors:  Sergey Doronin; Elena Shumay; Hsien-yu Wang; Craig C Malbon
Journal:  J Biol Chem       Date:  2002-01-24       Impact factor: 5.157

2.  Shc and CEACAM1 interact to regulate the mitogenic action of insulin.

Authors:  Matthew N Poy; Randall J Ruch; Mats A Fernstrom; Yoshinori Okabayashi; Sonia M Najjar
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

3.  Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.

Authors:  Rachel Zhande; John J Mitchell; Jiong Wu; Xiao Jian Sun
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Insulin stimulates phosphorylation of the beta 2-adrenergic receptor by the insulin receptor, creating a potent feedback inhibitor of its tyrosine kinase.

Authors:  Sergey Doronin; Hsien-yu Wang Hy; Craig C Malbon
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

5.  CEACAM1 regulates insulin clearance in liver.

Authors:  Matthew N Poy; Yan Yang; Khadijeh Rezaei; Mats A Fernström; Abraham D Lee; Yoshiaki Kido; Sandra K Erickson; Sonia M Najjar
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

Review 6.  Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities.

Authors:  Kevin D Niswender; Michael W Schwartz
Journal:  Front Neuroendocrinol       Date:  2003-01       Impact factor: 8.606

7.  Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons.

Authors:  Wen-Hua Zheng; Satyabrata Kar; Rémi Quirion
Journal:  Mol Pharmacol       Date:  2002-08       Impact factor: 4.436

8.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

9.  Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia.

Authors:  Kevin D Niswender; Christopher D Morrison; Deborah J Clegg; Ryan Olson; Denis G Baskin; Martin G Myers; Randy J Seeley; Michael W Schwartz
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

10.  Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs.

Authors:  Hui Zhang; Xiangming Zha; Yi Tan; Peter V Hornbeck; Allison J Mastrangelo; Dario R Alessi; Roberto D Polakiewicz; Michael J Comb
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

View more
  12 in total

1.  Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway.

Authors:  Corinne Bousquet; Julie Guillermet-Guibert; Nathalie Saint-Laurent; Elodie Archer-Lahlou; Frédéric Lopez; Marjorie Fanjul; Audrey Ferrand; Daniel Fourmy; Carole Pichereaux; Bernard Monsarrat; Lucien Pradayrol; Jean-Pierre Estève; Christiane Susini
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

2.  Adenosine A(1) receptor agonist N(6)-cyclohexyl-adenosine induced phosphorylation of delta opioid receptor and desensitization of its signaling.

Authors:  Yun Cheng; Yi-min Tao; Jian-feng Sun; Yu-hua Wang; Xue-jun Xu; Jie Chen; Zhi-qiang Chi; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2010-06-21       Impact factor: 6.150

3.  The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study.

Authors:  Andrea A Howard; Donald R Hoover; Kathryn Anastos; Xi Wu; Qiuhu Shi; Howard D Strickler; Stephen R Cole; Mardge H Cohen; Andrea Kovacs; Michael Augenbraun; Patricia S Latham; Phyllis C Tien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

4.  In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.

Authors:  Prabhat Singh; Bhupesh Sharma; Surbhi Gupta; B M Sharma
Journal:  Psychopharmacology (Berl)       Date:  2014-07-26       Impact factor: 4.530

5.  Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction.

Authors:  Liqi Tong; Robert Balazs; Rungtip Soiampornkul; Wipawan Thangnipon; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2007-04-27       Impact factor: 4.673

6.  Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study.

Authors:  Mahdi Nalini; Masoud Khoshnia; Farin Kamangar; Maryam Sharafkhah; Hossein Poustchi; Akram Pourshams; Gholamreza Roshandel; Samad Gharavi; Mahdi Zahedi; Alireza Norouzi; Masoud Sotoudeh; Arash Nikmanesh; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Arash Etemadi
Journal:  Int J Epidemiol       Date:  2021-03-03       Impact factor: 7.196

7.  Effects of heroin self-administration and forced withdrawal on the expression of genes related to the mTOR network in the basolateral complex of the amygdala of male Lewis rats.

Authors:  Marcos Ucha; David Roura-Martínez; Raquel Santos-Toscano; Roberto Capellán; Emilio Ambrosio; Alejandro Higuera-Matas
Journal:  Psychopharmacology (Berl)       Date:  2022-04-25       Impact factor: 4.415

8.  Numb-dependent integration of pre-TCR and p53 function in T-cell precursor development.

Authors:  N M Martin-Blanco; S Checquolo; F Del Gaudio; R Palermo; G Franciosa; L Di Marcotullio; A Gulino; M Canelles; I Screpanti
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

9.  The protective effects of human milk-derived peptides on the pancreatic islet biology.

Authors:  Amitoj Singh; Ashwantha Kumar Enjapoori; Yann Gibert; Karen M Dwyer
Journal:  Biol Open       Date:  2020-08-14       Impact factor: 2.422

10.  Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone.

Authors:  Igor Elman; Margaret Howard; Jacob T Borodovsky; David Mysels; David Rott; David Borsook; Mark Albanese
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.